{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
ethanolamine oleate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
M020
(2025)
Source URL:
First approved in 2017
Source:
21 CFR 348
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M016
(2023)
Source URL:
First approved in 2016
Source:
21 CFR 347
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Krx Aesthetics All Day Glow Sunblocker by KRX RESOURCES SDN. BHD.
(2024)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA065078
(2005)
Source URL:
First approved in 2005
Source:
ANDA065078
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(2003)
Source URL:
First approved in 2003
Source:
21 CFR 333C
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M032
(1997)
Source URL:
First approved in 1997
Source:
M032
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Class:
POLYMER
Status:
US Approved Rx
(2016)
Source:
NDA207648
(2016)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 346.14(a)(2) anorectal:protectant cocoa butter
Source URL:
First approved in 1964
Source:
21 CFR 346
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2010)
Source:
ANDA090146
(2010)
Source URL:
First approved in 1982
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Ciclopirox is an antifungal medication indicated for the treatment of seborrheic dermatitis (Loprox trade name) and onychomycosis of fingernails and toenails due to Trichophyton rubrum (Penlac trade name). The drug exerts its action by chelating Fe3+ and Al3+, resulting in the inhibition of the metal-dependent enzymes that are responsible for the degradation of peroxides within the fungal cell.
